Justin W. Yorke - Oct 12, 2023 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Oct 12, 2023
Transactions value $
$1,800
Form type
4/A - Amendment
Date filed
10/23/2023, 05:31 PM
Date Of Original Report
Oct 12, 2023
Previous filing
Oct 10, 2023
Next filing
Nov 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $1.8K +6K +8.73% $0.30 74.7K Oct 12, 2023 Direct F1
holding PCSA Common Stock 520K Oct 12, 2023 By Richland Fund, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amendment filed solely to correct the amount directly owned reported on the Form 4 filed October 12, 2023 and the Form 4 filed on October 10/10/2023.